For example, in hepatocellular carcinoma (HCC), miR-23b directly targets the 3’UTR of PYK2 and reduces the level of PYK2 protein, thereby inhibiting epithelial-mesenchymal transition (EMT) and tumor metastasis. This evidence concerns the gene PTK2B and hepatocellular carcinoma.